JP2022514739A5 - - Google Patents
Info
- Publication number
- JP2022514739A5 JP2022514739A5 JP2021534981A JP2021534981A JP2022514739A5 JP 2022514739 A5 JP2022514739 A5 JP 2022514739A5 JP 2021534981 A JP2021534981 A JP 2021534981A JP 2021534981 A JP2021534981 A JP 2021534981A JP 2022514739 A5 JP2022514739 A5 JP 2022514739A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- composition according
- integer
- formula
- aging composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862780488P | 2018-12-17 | 2018-12-17 | |
| US62/780,488 | 2018-12-17 | ||
| US201962804411P | 2019-02-12 | 2019-02-12 | |
| US62/804,411 | 2019-02-12 | ||
| US201962834794P | 2019-04-16 | 2019-04-16 | |
| US62/834,794 | 2019-04-16 | ||
| PCT/US2019/066553 WO2020131704A1 (en) | 2018-12-17 | 2019-12-16 | Triple combination therapies for anti-aging |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022514739A JP2022514739A (ja) | 2022-02-15 |
| JP2022514739A5 true JP2022514739A5 (enExample) | 2022-12-26 |
| JP7641897B2 JP7641897B2 (ja) | 2025-03-07 |
Family
ID=71102298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534981A Active JP7641897B2 (ja) | 2018-12-17 | 2019-12-16 | 抗加齢のための三剤組合せ療法 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11918597B2 (enExample) |
| EP (1) | EP3897659A4 (enExample) |
| JP (1) | JP7641897B2 (enExample) |
| KR (1) | KR20210104830A (enExample) |
| CN (1) | CN113453690A (enExample) |
| AU (1) | AU2019402099B2 (enExample) |
| BR (1) | BR112021011964A2 (enExample) |
| CA (1) | CA3123850A1 (enExample) |
| CL (1) | CL2021001617A1 (enExample) |
| CO (1) | CO2021009008A2 (enExample) |
| CR (1) | CR20210351A (enExample) |
| DO (1) | DOP2021000123A (enExample) |
| EC (1) | ECSP21052757A (enExample) |
| IL (1) | IL284059B2 (enExample) |
| MX (1) | MX2021007347A (enExample) |
| PE (1) | PE20220499A1 (enExample) |
| PH (1) | PH12021551435A1 (enExample) |
| SG (1) | SG11202106532WA (enExample) |
| WO (1) | WO2020131704A1 (enExample) |
| ZA (1) | ZA202104254B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210072026A (ko) | 2018-10-02 | 2021-06-16 | 루넬라 바이오테크 인코포레이티드 | 세놀리틱 약물로서 아지트로마이신 및 록시스로마이신 유도체 |
| EP3923941B1 (en) | 2019-02-12 | 2025-12-03 | Novartis AG | Pharmaceutical combination comprising tno155 and ribociclib |
| BR112022022185A2 (pt) * | 2020-05-13 | 2022-12-13 | Lunella Biotech Inc | Derivados de miristoíla de 9-amino-doxiciclina para alvejar células-tronco cancerígenas e prevenir metástase |
| WO2025114970A1 (en) * | 2023-11-30 | 2025-06-05 | Lunella Biotech, Inc. | Senolytic compositions |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK149776C (da) * | 1984-01-06 | 1987-04-21 | Orion Yhtymae Oy | Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen |
| US6805880B1 (en) * | 1999-08-20 | 2004-10-19 | Ferrosan A/S | Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress |
| RU2223103C1 (ru) * | 2002-07-17 | 2004-02-10 | Открытое акционерное общество "Биосинтез" | Фармацевтическая композиция, обладающая антибактериальным действием |
| CN1837229A (zh) * | 2005-08-05 | 2006-09-27 | 济南思创生物技术有限公司 | 克拉霉素衍生物及其制备方法和药物应用 |
| US7282225B1 (en) * | 2006-09-27 | 2007-10-16 | Occular Technologies, Inc. | Composition and methods for improving retinal health |
| US8168597B2 (en) * | 2008-10-22 | 2012-05-01 | Inspire Pharmaceuticals, Inc. | Method for treating cystic fibrosis |
| WO2012112945A1 (en) * | 2011-02-18 | 2012-08-23 | The Trustees Of Columbia University In The City Of New York | Use of matrix metalloproteinase inhibitors to treat tuberculosis |
| WO2013024467A2 (en) | 2011-08-18 | 2013-02-21 | Ecole Polytechnique Federale De Lausanne (Epfl) | Mitochondrial ribosomal proteins as aging regulators |
| US9775855B2 (en) * | 2011-09-14 | 2017-10-03 | Thomas J. Lewis | Compositions comprising macrolide and tetracycline and their uses |
| GB201217310D0 (en) * | 2012-09-27 | 2012-11-14 | C10 Pharma As | Compounds |
| CN103536530A (zh) * | 2013-10-30 | 2014-01-29 | 王玉万 | 盐酸多西环素长效注射剂及制备方法 |
| US11311501B2 (en) * | 2017-03-15 | 2022-04-26 | Lunella Biotech, Inc. | Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast |
| WO2018193116A1 (en) * | 2017-04-20 | 2018-10-25 | Novintum Biotechnology Gmbh | Azithromycin derivatives containing a phosphonium ion as anticancer agents |
| US11197872B2 (en) | 2017-04-21 | 2021-12-14 | Lunella Biotech, Inc. | Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs) |
| PH12019502594A1 (en) * | 2017-05-19 | 2020-10-26 | Lunella Biotech Inc | Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| US11883497B2 (en) * | 2017-08-29 | 2024-01-30 | Puretech Lyt, Inc. | Lymphatic system-directing lipid prodrugs |
| KR20210072026A (ko) * | 2018-10-02 | 2021-06-16 | 루넬라 바이오테크 인코포레이티드 | 세놀리틱 약물로서 아지트로마이신 및 록시스로마이신 유도체 |
| AU2019403048B2 (en) * | 2018-12-17 | 2025-01-23 | Lunella Biotech, Inc. | Triple combination therapies for targeting mitochondria and killing cancer stem cells |
-
2019
- 2019-12-16 AU AU2019402099A patent/AU2019402099B2/en active Active
- 2019-12-16 SG SG11202106532WA patent/SG11202106532WA/en unknown
- 2019-12-16 MX MX2021007347A patent/MX2021007347A/es unknown
- 2019-12-16 KR KR1020217022471A patent/KR20210104830A/ko not_active Ceased
- 2019-12-16 CN CN201980091563.7A patent/CN113453690A/zh active Pending
- 2019-12-16 CR CR20210351A patent/CR20210351A/es unknown
- 2019-12-16 BR BR112021011964-7A patent/BR112021011964A2/pt unknown
- 2019-12-16 JP JP2021534981A patent/JP7641897B2/ja active Active
- 2019-12-16 PE PE2021000909A patent/PE20220499A1/es unknown
- 2019-12-16 WO PCT/US2019/066553 patent/WO2020131704A1/en not_active Ceased
- 2019-12-16 EP EP19900644.6A patent/EP3897659A4/en active Pending
- 2019-12-16 CA CA3123850A patent/CA3123850A1/en active Pending
- 2019-12-16 US US17/414,853 patent/US11918597B2/en active Active
-
2021
- 2021-06-15 IL IL284059A patent/IL284059B2/en unknown
- 2021-06-17 CL CL2021001617A patent/CL2021001617A1/es unknown
- 2021-06-17 DO DO2021000123A patent/DOP2021000123A/es unknown
- 2021-06-17 PH PH12021551435A patent/PH12021551435A1/en unknown
- 2021-06-21 ZA ZA2021/04254A patent/ZA202104254B/en unknown
- 2021-07-08 CO CONC2021/0009008A patent/CO2021009008A2/es unknown
- 2021-07-16 EC ECSENADI202152757A patent/ECSP21052757A/es unknown
-
2024
- 2024-01-29 US US18/425,427 patent/US20240316086A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022514739A5 (enExample) | ||
| ES3013603T3 (en) | A composition for weight loss or weight management comprising beta-hydroxybutyrate and cannabidiol | |
| JP6141929B2 (ja) | アントシアニジンを含む組成物及び使用方法 | |
| AU2001253919B2 (en) | Administration of a thiol-based chemoprotectant compound | |
| AU2023222925B2 (en) | Strontium based compositions and formulations for pain, pruritus, and inflammation | |
| WO2010129337A3 (en) | New oral formulations for tetrapyrrole derivatives | |
| JP2021008509A (ja) | トコトリエノールの経粘膜送達 | |
| JP2020534362A (ja) | 成人における焦点てんかんの処置のための合成経皮的カンナビジオール | |
| US11896598B2 (en) | Appetite suppressant compositions and methods thereof | |
| US20250099498A1 (en) | Strontium based compositions and formulations for pain, pruritus, and inflammation | |
| Kessler et al. | Hearing loss during chemotherapy: prevalence, mechanisms, and protection | |
| EP3461479B1 (en) | Nutraceutical and pharmaceutical compositions, and uses thereof for preserving cognitive functions | |
| CZ285000B6 (cs) | Antiemetické kompozice | |
| WO2021099453A1 (fr) | Extrait liquide aqueux de spiruline pour la prévention et/ou le traitement des neuropathies périphériques chimio-induites et leurs symptômes, composition et utilisation correspondantes | |
| US20170157169A1 (en) | Strontium based compositions and formulations for pain, pruritus, and inflammation | |
| CA3074541C (en) | Appetite suppressant compositions and methods thereof | |
| JP6322575B2 (ja) | 脂質マイクロカプセルのデリバリービヒクルを含む局所用製剤およびその使用 | |
| Vadivelan et al. | The ‘golden hour’in paraquat poisoning | |
| RU2021121094A (ru) | Тройная комбинированная терапия против старения | |
| ES2207166T3 (es) | Composicion fungicida que comprende una benzoilfenilurea. | |
| RU2019110755A (ru) | Сублингвальное или буккальное введение dim для лечения заболеваний кожи | |
| EP1965791B1 (de) | Neue kompositionen gegen alkyl-acyl-gpc, seine derivate und produkte | |
| RU95107140A (ru) | Способ лечения генерализованной формы демодекоза собак, осложненной стафилококкозом и грибковой инфекцией | |
| CA3167614C (en) | Nutritional compositions and methods containing a lignan and a methyl donor | |
| CA2958169A1 (en) | Strontium based compositions and formulations for pain, pruritus, and inflammation |